Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (3), 768-778
- https://doi.org/10.1016/j.ygyno.2006.10.062
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancerGynecologic Oncology, 2006
- Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian CarcinomaCancer Research, 2006
- Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyClinical Cancer Research, 2006
- Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical ResultsJournal of Clinical Oncology, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular endothelial growth factor in cervical carcinomaPublished by Wolters Kluwer Health ,1999
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990